Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025年3月11日 - 5:30AM
Edgar (US Regulatory)
Exhibit
99
JOINT
FILING AGREEMENT
In
accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that
they are jointly filing this statement on Schedule 13G. Each of them is responsible for the timely filing of such statement and any amendments
thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible
for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason
to believe that such information is inaccurate.
IN
WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of March 10, 2025.
|
ABG
Management Ltd. |
|
|
|
|
By: |
/s/
Fan Yu |
|
Name: |
Fan
Yu |
|
Title: |
Director |
|
|
|
|
Ally
Bridge Group (NY) LLC |
|
By:
ABG Management Ltd., its managing member |
|
|
|
|
By: |
/s/
Fan Yu |
|
Name: |
Fan
Yu |
|
Title: |
Director |
|
|
|
|
Ally
Bridge MedAlpha Master Fund L.P. |
|
By:
Ally Bridge Group (NY) LLC, its manager |
|
By:
ABG Management Ltd., its managing member |
|
|
|
|
By: |
/s/
Fan Yu |
|
Name: |
Fan
Yu |
|
Title: |
Director |
|
|
|
|
ABG
Innovation Capital Partners III GP Limited |
|
|
|
|
By: |
/s/
Fan Yu |
|
Name: |
Fan
Yu |
|
Title: |
Director |
|
|
|
|
ABG
Innovation Capital Partners III GP, L.P. |
|
By:
ABG Innovation Capital Partners III GP Limited, its general partner |
|
|
|
|
By: |
/s/
Fan Yu |
|
Name: |
Fan
Yu |
|
Title: |
Director |
|
|
|
|
Ally
Bridge Group Innovation Capital Partners III, L.P. |
|
By:
ABG Innovation Capital Partners III GP, L.P., its general partner |
|
By:
ABG Innovation Capital Partners III GP Limited, its general partner |
|
|
|
|
By: |
/s/
Fan Yu |
|
Name: |
Fan
Yu |
|
Title: |
Director |
|
|
|
|
ABG
Innovation-SO Limited |
|
|
|
|
By: |
/s/
Shan-ju Yeh |
|
Name: |
Shan-ju
Yeh |
|
Title: |
Director |
|
|
|
|
ABG
Global Life Science Capital Partners V GP Limited |
|
|
|
|
By: |
/s/
Shan-ju Yeh |
|
Name: |
Shan-ju
Yeh |
|
Title: |
Director |
|
|
|
|
ABG
Global Life Science Capital Partners V GP, L.P. |
|
By:
ABG Global Life Science Capital Partners V GP Limited, its general partner |
|
|
|
|
By: |
/s/
Shan-ju Yeh |
|
Name: |
Shan-ju
Yeh |
|
Title: |
Director |
|
|
|
|
Ally
Bridge Group Global Life Science Capital Partners V, L.P. |
|
By:
ABG Global Life Science Capital Partners V GP, L.P., its general partner |
|
|
|
|
By: |
/s/
Shan-ju Yeh |
|
Name: |
Shan-ju
Yeh |
|
Title: |
Director |
|
|
|
|
ABG-SIV,
L.P. |
|
By:
ABG Global Life Science Capital Partners V GP, L.P., its general partner |
|
|
|
|
By: |
/s/
Shan-ju Yeh |
|
Name: |
Shan-ju
Yeh |
|
Title: |
Director |
|
|
|
|
ABG
V-SIV Limited |
|
|
|
|
By: |
/s/
Shan-ju Yeh |
|
Name: |
Shan-ju
Yeh |
|
Title: |
Director |
|
|
|
|
Mr.
Fan Yu |
|
|
|
|
|
/s/
Fan Yu |
|
Name: |
Fan
Yu |
Aadi Bioscience (NASDAQ:AADI)
過去 株価チャート
から 3 2025 まで 4 2025
Aadi Bioscience (NASDAQ:AADI)
過去 株価チャート
から 4 2024 まで 4 2025